Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07128316 · ClinicalTrials.gov registry record · NA
LASIK Using Contoura With Phorcides vs. iDesign
A NA study of Myopia and Astigmatism, sponsored by 59th Medical Wing.
- Active
- Registry status
- NA
- Development phase
- 63
- Enrollment target
- 1
- Study location
NCT07128316 is a NA study of Myopia and Astigmatism that is active but no longer recruiting, run by 59th Medical Wing. The registered enrollment target is 63 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07128316, a NA study of Myopia and Astigmatism, is active but no longer recruiting, sponsored by 59th Medical Wing.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
- 1
- Study location
Study Summary
Participants will undergo LASIK using Contoura with Phorcides calculation on one eye and LASIK using iDesign calculation on the contralateral eye to correct myopia.
Conditions Studied
Interventions
- DEVICE Contoura Topolyzer with Phorcides
- DEVICE iDesign
Study Locations (1)
Texas
- Joint Warfighter Refractive Surgery Center at WHASC - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2023-09-11 |
| Est. Completion | 2025-12-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07128316
The ClinicalTrials.gov registry entry for NCT07128316 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (76% lower). The listed sponsor is 59th Medical Wing, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which Contoura Topolyzer with Phorcides is the first listed.
NCT07128316 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT07128316 about?
NCT07128316 is a clinical study titled "LASIK Using Contoura With Phorcides vs. iDesign". Participants will undergo LASIK using Contoura with Phorcides calculation on one eye and LASIK using iDesign calculation on the contralateral eye to correct myopia.
What is the current status of trial NCT07128316?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 63 participants. The study started on 2023-09-11. Estimated completion is 2025-12-15.
What conditions does trial NCT07128316 study?
This clinical trial studies the following conditions: Myopia, Astigmatism.
What interventions are being tested in trial NCT07128316?
The interventions under investigation include: Contoura Topolyzer with Phorcides (DEVICE), iDesign (DEVICE).
Who is sponsoring clinical trial NCT07128316?
This trial is sponsored by 59th Medical Wing, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07128316 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
-
Wavelength Intervention for Nearsighted Kids
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.